Cargando…
PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1)
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428670/ http://dx.doi.org/10.1097/01.HS9.0000975800.84791.f4 |
| _version_ | 1785090524457205760 |
|---|---|
| author | Luminari, Stefano Kim, Tae Min Risal, Ashish Namuduri, Manjusha Cai, Jingxian Fearon-Chalet, Bertha Zhu, Min Mukherjee, Sushmita Brouwer-Visser, Jurriaan Chaudhry, Aafia Mohamed, Hesham Ambati, Srikanth Vitolo, Umberto |
| author_facet | Luminari, Stefano Kim, Tae Min Risal, Ashish Namuduri, Manjusha Cai, Jingxian Fearon-Chalet, Bertha Zhu, Min Mukherjee, Sushmita Brouwer-Visser, Jurriaan Chaudhry, Aafia Mohamed, Hesham Ambati, Srikanth Vitolo, Umberto |
| author_sort | Luminari, Stefano |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428670 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104286702023-08-17 PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1) Luminari, Stefano Kim, Tae Min Risal, Ashish Namuduri, Manjusha Cai, Jingxian Fearon-Chalet, Bertha Zhu, Min Mukherjee, Sushmita Brouwer-Visser, Jurriaan Chaudhry, Aafia Mohamed, Hesham Ambati, Srikanth Vitolo, Umberto Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428670/ http://dx.doi.org/10.1097/01.HS9.0000975800.84791.f4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Luminari, Stefano Kim, Tae Min Risal, Ashish Namuduri, Manjusha Cai, Jingxian Fearon-Chalet, Bertha Zhu, Min Mukherjee, Sushmita Brouwer-Visser, Jurriaan Chaudhry, Aafia Mohamed, Hesham Ambati, Srikanth Vitolo, Umberto PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1) |
| title | PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1) |
| title_full | PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1) |
| title_fullStr | PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1) |
| title_full_unstemmed | PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1) |
| title_short | PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1) |
| title_sort | pb2267: trial in progress: phase 3 trial evaluating the efficacy and safety of odronextamab versus investigator’s choice in previously untreated follicular lymphoma (olympia-1) |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428670/ http://dx.doi.org/10.1097/01.HS9.0000975800.84791.f4 |
| work_keys_str_mv | AT luminaristefano pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT kimtaemin pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT risalashish pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT namudurimanjusha pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT caijingxian pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT fearonchaletbertha pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT zhumin pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT mukherjeesushmita pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT brouwervisserjurriaan pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT chaudhryaafia pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT mohamedhesham pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT ambatisrikanth pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 AT vitoloumberto pb2267trialinprogressphase3trialevaluatingtheefficacyandsafetyofodronextamabversusinvestigatorschoiceinpreviouslyuntreatedfollicularlymphomaolympia1 |